News
News
- Italy signs Lufthansa's letter of intent for ITA stake
17:28 - TeleTrader - PTA-PVR: Wacker Chemie AG: Release according to Article 40, Section 1 of the WpHG
16:00 - pressetext - PTA-DD: 3U HOLDING AG: Correction of a Managers' transactions announcement according to article 19 MAR from 26.01.2023
13:03 - pressetext - Galecto Adds Experienced Biotech Executive Stephanie Oestreich as Chief Business Officer
01/05/2022 / 14:00 - GlobeNewswire - Awakn Life Sciences Identifies New Chemical Series via Its Drug Discovery Program
10/28/2021 / 13:30 - Newsfile Corp - Curexsys Appoints Christian Eckert as Chief Operating Officer
10/20/2021 / 10:00 - GlobeNewswire - Pasithea Therapeutics Corp. and Evotec SE Enter into Drug Development Agreement
10/11/2021 / 12:50 - GlobeNewswire - Chinook Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
05/12/2021 / 22:05 - GlobeNewswire - Awakn Life Sciences Initiates New Chemical Entity Development Program with Evotec as Research Partner and Addiction Expert, Prof. David Nutt, as Program Lead
04/27/2021 / 13:30 - Newsfile Corp - Chinook Therapeutics and Evotec Announce Strategic Collaboration to Discover and Develop Novel Precision Medicines for Chronic Kidney Diseases
03/01/2021 / 14:15 - GlobeNewswire
Real-time